Clinical trial
Autologous Incubated Macrophages for Patients With Complete Spinal Cord Injuries
NCT00073853 · Proneuron Biotechnologies, Industry · Suspended
Key facts
| NCT number | NCT00073853 |
|---|---|
| Title | Autologous Incubated Macrophages for Patients With Complete Spinal Cord Injuries |
| Official title | A Phase II Multicenter, Randomized-Controlled Study to Evaluate the Safety and Efficacy of Autologous Incubated Macrophages for the Treatment of Patients With Complete Spinal Cord Injuries |
| Lead sponsor | Proneuron Biotechnologies, Industry |
| Collaborators | The Marcus Foundation B.I.R.D. (Israel-U.S. Binational Industrial Research and Development) |
| Status | Suspended |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Spinal Cord Injury |
| Intervention type | Procedure |
| Interventions | Autologous Incubated Macrophages (cell therapy) |
| Enrollment | 61 |
| Start date | Sep 1, 2003 |
| First posted | Dec 11, 2003 |
| Last update posted | Aug 28, 2009 |
| Countries | Israel, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: